Voyager Therapeutics Prioritizes Pipeline With Cash Runway Into 2024
Voyager Therapeutics Inc (NASDAQ:VYGR) unveiled its prioritized therapeutic pipeline focusing on tau antibody for Alzheimer’s disease and gene therapies for GBA1…
Akebia’s Anemia Drug Disappoints In Mid-Stage COVID-19 Study
Akebia Therapeutics Inc (NASDAQ:AKBA) announced initial findings from an investigator-sponsored study evaluating vadadustat for Acute Respiratory Distress Syndrome (ARDS) with COVID-19…
iRhythm Reports Smaller Than Expected Q2 Loss; Narrows Annual Sales Guidance
iRhythm Technologies Inc (NASDAQ:IRTC) posted a Q2 adjusted loss of $(0.79) compared to a loss of $(0.59) a year ago, beating…
Kazia Therapeutics Shares Jump On Interim Data From Paxalisib Combo Study In Brain Metastases
Kazia Therapeutics Limited (NASDAQ:KZIA) announced the presentation of new data from an ongoing phase 1 trial of paxalisib in combination with…
Insulet Posts Q2 Revenue Beat, Lifts FY22 Guidance
Insulet Corporation (NASDAQ:PODD) posted a Q2 net loss of $(35) million, or an EPS loss of $(0.50) compared to $(0.37)…
FDA Asks For Additional Study For Acadia’s Pimavanserin In Alzheimer’s-Associated Delusions
The FDA has issued a Complete Response Letter (CRL) to Acadia Pharmaceuticals Inc (NASDAQ:ACAD) regarding its supplemental marketing application for pimavanserin in…
US Officials Declare Health Emergency Over Monkeypox Outbreak As Cases Cross 6,000 Mark: Report
The Biden administration has officially declared monkeypox a public health emergency as cases continue to rise in the U.S., the Wall Street Jour
Sanofi, Innovent Biologics Collaborate On Cancer Treatments In China
Innovent Biologics Inc (OTC:IVBXF) and Sanofi SA (NASDAQ:SNY) have collaborated to develop and commercialize two Sanofi clinical-stage oncology assets – Phase 3 SAR408701…
Pfizer Cuts Late-Stage Asset For Rare Cardiovascular Acquired Via $11.4B Array acquisition
Pfizer Inc (NYSE:PFE) announced that an interim futility analysis of the global Phase 3 trial, REALM-DCM of PF-07265803, indicated…
Novavax Starts Late-Stage COVID-19 Vaccine Study In Children Below 11 Years
Novavax Inc (NASDAQ:NVAX) has initiated its Phase 2b/3 Hummingbird trial to evaluate the safety, effectiveness, and efficacy of two doses of…